Article
Generation of Recombinant SARS‐CoV‐2 Using a Bacterial Artificial Chromosome
13 Oct 2020
Abstract excerpt
SARS-CoV-2, the causative agent of COVID-19, has been responsible for a million deaths worldwide as of September 2020. At the time of this writing, there are no available US FDA-approved therapeutics for the treatment of SARS-CoV-2 infection. Here, we describe a detailed protocol to generate recombinant (r)SARS-CoV-2 using reverse-genetics approaches based on the use of a bacterial artificial chromosome (BAC)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
